LXRX - Lexicon announces oversubscribed $250M private placement of equity securities
2024-03-11 11:52:44 ET
More on Lexicon Pharmaceuticals
- Lexicon Pharmaceuticals Putting The Pieces Together, But Much Is Left To Do
- Lexicon Pharma: Inpefa's Early Clinical Benefits, Rehospitalization Data May Unlock Significant Value
- Lexicon Pharmaceuticals: Navigating The Competitive HFpEF Landscape (Rating Downgrade)